RE: Exciting Insights from Tim McCarthy's Interview on ImmuPharma's Future25 Jan 2025 10:54
In the event of share price performance in excess of the assumptions made, the Company would have a longer cash runway as there would be a higher level of cash receipts under the various Lanstead Agreements. In addition, a higher share price would increase the likelihood of the exercise of outstanding Options and warrants, which would result in further cash receipts for the Company